Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-8 replication by antagonism of the chemokine receptor CXCR4

被引:112
作者
Bridger, GJ
Skerlj, RT
Padmanabhan, S
Martellucci, SA
Henson, GW
Struyf, S
Witvrouw, M
Schols, D
De Clercq, E
机构
[1] AnorMED Inc, Langley, BC V2Y 1N5, Canada
[2] Johnson Matthey Pharmaceut Res, W Chester, PA 19380 USA
[3] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
D O I
10.1021/jm990211i
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Bis-tetraazamacrocycles such as the bicyclam AMD3100 are a class of potent and selective anti-HIV-1 and HIV-2 agents that inhibit virus replication by binding to the chemokine receptor CXCR4, the co-receptor for entry of X4 viruses. With the aim of optimizing the anti-HIV-1 and HIV-2 activity of bis-azamacrocycles, a series of analogues were synthesized which contain neutral heteroatom (oxygen, sulfur) or heteroaromatic (of lower pK(a) than a secondary amine) replacements for the amino groups of AMD3100. The introduction of one or more heteroatoms such as oxygen or sulfur into the macrocyclic ring of p-phenylenebis(methylene)-linked dimers (to give N3X or N2X2 bis-macrocycles) gave analogues with substantially reduced anti-HIV-1 (IIIB) and anti-HIV-2 (ROD) potency. In addition, the bis-sulfur analogue was also markedly more cytotoxic to MT-4 cells. However, bis-tetraazamacrocycles featuring a single pyridine group incorporated within the macrocyclic framework: exhibited anti-HIV-l and HIV-2 potency comparable to that of their saturated, aliphatic counterparts. The p-phenylenebis(methylene)-linked dimer of the py[14]aneN(4) macrocycle inhibited HIV-1 replication at a 50% effective concentration (EC50) of 0.5 mu M while remaining nontoxic to MT-4 cells at concentrations approaching 200 mu M. A series of analogues containing macrocyclic heteroaromatic groups of varying pK(a) were also synthesized, and their ability to inhibit HN replication was evaluated. Replacing the pyridine moiety of the py[14]aneN(4) macrocyclic ring with pyrazine or pyridine groups substituted in the 4-position (with electron-withdrawing or -donating groups) either reduced antiviral potency or increased cytotoxicity to MT-4 cells. Finally, we synthesized a series of analogues in which the ring size of the bis-pyridyl macrocycles was varied between 12 and 16 members per ring including the py[iso-14]aneN(4) ring system, an isomer of the py[14]aneN(4) macrocycle. The p-phenylenebis(methylene)-linked dimer of the py[iso-14]aneN4 (AMD3329) displayed the highest antiviral activity of the bis-azamacrocyclic analogues reported to date, exhibiting EC50's against the cytopathic effects of HIV-1 and HIV-2 replication of 0.8 and 1.6 nM, respectively, that is, about 3-5-fold lower than the EC50 Of AMD3100. AMD3329 also inhibited the binding of a specific CXCR4 mAb and the Ca2+ flux induced by SDF-1 alpha, the natural ligand for CXCR4, more potently than AMD3100. Furthermore, AMD3329 also interfered with virus-induced syncytium formation at an EC50 Of 12 nM.
引用
收藏
页码:3971 / 3981
页数:11
相关论文
共 21 条
  • [1] Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication .2. Effect of heteroaromatic linkers on the activity of bicyclams
    Bridger, GJ
    Skerlj, RT
    Padmanabhan, S
    Martellucci, SA
    Henson, GW
    Abrams, MJ
    Joao, HC
    Witvrouw, M
    DeVreese, K
    Pauwels, R
    DeClercq, E
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) : 109 - 119
  • [2] SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF PHENYLENEBIS(METHYLENE)-LINKED BIS-TETRAAZAMACROCYCLES THAT INHIBIT HIV REPLICATION - EFFECTS OF MACROCYCLIC RING SIZE AND SUBSTITUENTS ON THE AROMATIC LINKER
    BRIDGER, GJ
    SKERLJ, RT
    THORNTON, D
    PADMANABHAN, S
    MARTELLUCCI, SA
    HENSON, GW
    ABRAMS, MJ
    YAMAMOTO, N
    DEVREESE, K
    PAUWELS, R
    DECLERCQ, E
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (02) : 366 - 378
  • [3] A versatile intermediate for the preparation of c-functionalized azamacrocycles and application to the synthesis of the potent Anti-HIV agent (+/-)JM2936
    Bridger, GJ
    Skerlj, RT
    Padmanabhan, S
    Thornton, D
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (04) : 1519 - 1522
  • [4] METAL-COMPLEXES OF MACROCYCLIC LIGANDS CONTAINING PYRIDINE
    COSTA, J
    DELGADO, R
    [J]. INORGANIC CHEMISTRY, 1993, 32 (23) : 5257 - 5265
  • [5] Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry
    Datema, R
    Rabin, L
    Hincenbergs, M
    Moreno, MB
    Warren, S
    Linquist, V
    Rosenwirth, B
    Seifert, J
    McCune, JM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) : 750 - 754
  • [6] HIGHLY POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS BY THE BICYCLAM DERIVATIVE JM3100
    DE CLERCQ, E
    YAMAMOTO, N
    PAUWELS, R
    BALZARINI, J
    WITVROUW, M
    DEVREESE, K
    DEBYSER, Z
    ROSENWIRTH, B
    PEICHL, P
    DATEMA, R
    THORNTON, D
    SKERLJ, R
    GAUL, F
    PADMANABHAN, S
    BRIDGER, G
    HENSON, G
    ABRAMS, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) : 668 - 674
  • [7] POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-1 AND HIV-2 REPLICATION BY A CLASS OF BICYCLAMS INTERACTING WITH A VIRAL UNCOATING EVENT
    DECLERCO, E
    YAMAMOTO, N
    PAUWELS, R
    BABA, M
    SCHOLS, D
    NAKASHIMA, H
    BALZARINI, J
    DEBYSER, Z
    MURRER, BA
    SCHWARTZ, D
    THORNTON, D
    BRIDGER, G
    FRICKER, S
    HENSON, G
    ABRAMS, M
    PICKER, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) : 5286 - 5290
  • [8] TOWARD IMPROVED ANTI-HIV CHEMOTHERAPY - THERAPEUTIC STRATEGIES FOR INTERVENTION WITH HIV-INFECTIONS
    DECLERCQ, E
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (14) : 2491 - 2517
  • [9] The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding
    DeVreese, K
    Reymen, D
    Griffin, P
    Steinkasserer, A
    Werner, G
    Bridger, GJ
    Este, J
    James, W
    Henson, GW
    Desmyter, J
    Anne, J
    DeClercq, E
    [J]. ANTIVIRAL RESEARCH, 1996, 29 (2-3) : 209 - 219
  • [10] AMD310, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
    Donzella, GA
    Schols, D
    Lin, SW
    Esté, JA
    Nagashima, KA
    Maddon, PJ
    Allaway, GP
    Sakmar, TP
    Henson, G
    De Clercq, E
    Moore, JP
    [J]. NATURE MEDICINE, 1998, 4 (01) : 72 - 77